Taurine references
Airaksinen EM, Oja SS, Marnela KM, Sihvola P. Taurine and other amino acids of platelets and plasma in retinitis pigmentosa. Ann Clin Res 1980;12(2):52-4.
Airaksinen EM et al. Effects of taurine treatment on epileptic patients. Prog Clin Biol Res 1980;39:157-66.
Airaksinen EM, Airaksinen MM, Marnela KM. Decrease in the uptake and concentration of taurine in blood platelets of retinitis pigmentosa patients. Metab Pediatr Ophthalmol 1981; 5(1):45-8.
Arshinoff SA, McCulloch JC, Macrae W, et al. Amino acids in retinitis pigmentosa. Br J Ophthalmol 1981; :626-30.
Azuma J et al. Taurine for treatment of congestive heart failure. Int J Cardiol 1982;2:303.
Azuma, J, et al. Taurine and congestive heart failure. Circulation Research 1983;34(4):543-57.
Azuma J et al. Therapy of congestive heart failure with orally administered taurine. Clin Ther 1983;5(4):398-408.
Azuma J, Sawamura A, Awata N, et al. Double-blind randomized crossover trial of taurine in congestive heart failure. Curr Ther Res 1983;34(4):543-57.
Azuma J et al. Beneficial effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits. Res Comm Chem Pathol Pharmacol 1984;435:261.
Azuma J, Sawamura A, Awata N, et al. Therapeutic effect of taurine in congestive heart failure: A double-blind crossover trial. Clin Cardiol 1985;8:276-82.
Azuma J, Takihara K, Awata N, et al. Taurine and failing heart: Experimental and clinical aspects. Prog Clin Biol Res 1985; 179:195-213.
Azuma J, Katsume H, Kagoshima T, et al. Clinical evaluation of taurine in congestive heart failure - a double blind study using CoQ10 as a control drug, in H Iwata, JB Lombardini, T Segawa, Eds. Taurine and the Heart. Boston, Kluwer Academic Publishers, 75-97, 1989.
Azuma J, Sawamura A, Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J 1992;56(1):95-9.
Barbeau A, Donaldson J. Zinc, taurine, and epilepsy. Arch Neurol 30:52-8, 1974.
Barnet KC, Curtis R. Retinal degenerations in the dog and cat as models for retinitis pigmentosa. Trans Ophthalmol Soc U K 103 (pt 4):448-52, 1983.
Baskin SL, Dagirmanjian R. Possible involvement of taurine in the genesis of muscular dystrophy. Nature 1973;245:464-5.
Basun H et al. Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects. J Neural Transm (P-D sect) 2:295-304, 1990.
Bellentani S et al. Taurine increases bile acid pool size and reduces bile saturation index in the hamster. J Lipid Res 1987; 28(9):1021-7.
Benini G, Marconcini C, Wirth A, Montagnoli G. Is taurine a marker for retinitis
pigmentosa? Ophthalmologica 1988; 197(3):130-5.
Bergamini L, Mutani R, Delsedime M, Durelli L. First clinical experience on the antiepileptic action of taurine. Eur Neurol 1974; 11(5):261-9.
Bruinvels J, Pepplinkhuizen L. Impaired glycine-serine conversion and increased plasma taurine levels in episodic psychotic patients with psychedelic symptoms. J Psychiatr Res 18(3):307-18, 1984.
Canadian Chemical Process Industri, 26:569-70, 1942.
Chazov EL et al. Taurine and electrical activity of the heart. Circ Res 1974;35 Suppl. 3:11-21.
Crass MF, Lombardini JB. Release of tissue taurine from the oxygen-deficient perfused rat heart. Proc Soc Exp Biol Med 157:486-8, 1978.
Desai TK et al. Taurine deficiency after intensive chemotherapy and/or radiation. Am J Clin Nutr 55:708-11, 1992.
Dorvil NP, et al. Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs. Am J Clin. Nutr. 1983;37(2):221-32.
Durelli L, Mutani R, Fassio F, et al. Taurine and the hyperexcitable human muscle: effect of taurine on potassium-induced hyperexcitability of dystrophic myotonic and normal muscles. Ann Neurol 11:258-65, 1982.
Durelli L, Mutani R, Fassio F. The treatment of myotonia: Evaluation of chronic oral taurine therapy. Neurology 33:599-603, 1983.
Feeney-Burns L et al. Macular pathology in monkeys fed semipurified diets. Prog Clin Biol Res 314:601-22, 1989.
Fekkes D, Pepplinkhuizen L, Bruinvels J. Changes in serine metabolism by a serum factor present in a group of episodic psychotic patients. Biol Psychiatry 30(1):966-72, 1991.
Fekkes D, Pepplinkhuizen L, Verheij R, Bruinvels J. Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis. Psychiatry Res 1994;5191):11-18.
Franconi F et al. The protective effect of taurine on hypoxia (performed in the absence of glucose) and on reoxygenation (in the presence of glucose) in guinea-pig heart. Biochem Pharmacol 1985;34(15):2611-15.
Franconi F, Bennardini F, Mattana A, et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61:1115-9, 1995.
Fujita T, Ando K, Noda H, et al. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75:525-32, 1987.
Hartley SG et al. Urinary excretion of taurine in epilepsy. Neurochem Res 14(2):149-52, 1989.
Hayes KC et al. Retinal degeneration associated with taurine deficiency in the cat. Science 188:949-51, 1975.
Hayes KC et al. Taurine modulates platelet aggregation in cats and humans. Am J Clin Nutr 49:1211-16, 1989.
Headache Journal, Vol 22, No 4: 165, 1982.
Huxtable R, Laird H. The prolonged anticonvulsant action of taurine on genetically determined seizure-susceptibility. Can J Neurol Sci 5:220, 1978.
Huxtable, R and Pasante-Morales, H., Taurine in Nutrition and Neurology, Plenum Press, 1982.
Imaki H et al. Retinal degeneration in 3-month-old rhesus monkey infants fed a taurine-free human infant formula. J Neurosci Res 18(4):602-14, 1987.
International Clinical Nutrition Review, Vol 2, No 3, 1982.
Kulakowski EC, Maturo J. Hypoglycemic properties of taurine not mediated by enhanced insulin release. Biochem Pharmacol 33:2835-8, 1984.
Lake N, Malik N. Retinal morphology in rats treated with a taurine transport antagonist. Exp Eye Res 44(3):331-46, 1987.
Life Science, 22:1789-98, 1978.
Lombardini, J. et al. Elevated blood taurine levels in acute myocardial infarction, Journal of Laboratory and Clinical Medicine, 98(6):849-59, 1981.
Lombardini JB. Taurine and retinal function. Brain Res Brain Res Rev 16(2):151-69, 1991.
Mantovani J et al. Effects of taurine on seizures and growth hormone release in epileptic patients. Arch Neurol 35:672, 1979.
Masuda M et al. Influences of taurine on functions of rat neutrophils. Jpn J Pharmacol 34(1):116-18, 1984.
Matsuyama Y, Morita T, Higuchi M, Tsujii T. The effect of taurine administration on patients with acute hepatitis, in K Kuriyama, RJ Huxtable, H Iwata, Eds. Sulfur Amino Acids: Biochemical and Clinical Aspects. New York, Alan R. Liss, Inc., 461-8, 1983.
Matsuzaki Y et al. Is taurine effective for treatment of painful muscle cramps in liver cirrhosis? Am J Gastroenterol 88:1466-7, 1993.
Maturo J, Kulakowsky EC. Taurine binding to the purified insulin receptor. Biochem Pharmacol 33:3755-60, 1988.
Monaco F, et al. Free Amino Acids in Serum of Patients with Epilepsy: Significant Increase in Taurine. Epilepsia 1975;16(2):245-49.
Nakamura-Yamanaka Y et al. Effect of dietary taurine on cholesterol 7 alpha-hydroxylase activity in the liver of mice fed a lithogenic diet. J Nutr Sci Vitaminol (Tokyo) 33(3):239-43, 1987.
Nature, 194:300-2, 1962.
Orthomolecular Rewiew, Vol 3. No 3, 1983.
Pomara N et al. Glutamate and other CSF amino acids in Alzheimer's disease. Am J Psychiatry 149(2):251-4, 1992.
Proceedings Nat. Adad. Sciences 78:564-78, 1978.
Read WO, Welty JD. Effect of taurine on epinephrine and digoxin induced irregularities of the dog heart. J Pharmacol Exp Ther 139:283-9, 1963.
Roe DA. Current concepts of the low taurine diet in psoriasis. Cutis 2:1013-20, 1966.
Scharschmidt BF et al. Effect of taurine on the isolated retinal pigment epithelium of the frog: electrophysiologic evidence for stimulation of an apical, electrogenic Na + -K + pump. J Membr Biol 106(1):71-81, 1988.
Schurr A et al. Taurine improves the recovery of neuronal function following cerebral hypoxia: An in vitro study. Life Sci 1987;40(21):2059-66.
Sebring LA, Huxtable RJ. Cardiovascular actions of taurine, in Sulfur Amino Acids: Biochemical & Clinical Aspects, 1983.
Shustova TI et al. Effect of taurine on potassium, calcium and sodium levels in the blood and tissues of rats. Vopr Med Khim 32(4):113-116, 1986.
Sturman J. Taurine in nutrition. Compr Ther 3:64, 1977; Van Gelder NM et al. Amino acid content of epileptogenic human brain: Focal versus surrounding regions. Brain Res 40:385-93, 1972.
Takihara K et al. Beneficial effect of taurine in rabbits with chronic congestive heart failure. Am Heart J 112:1278, 1986.
Tanno N et al. Effect of taurine administration on serum lipid and biliary lipid composition in man. Tohoku J Exp Med 159(2):91-100, 1989.
Uma SM, Statpahty M, Sitaramayya A. Decreased plasma taurine levels in retinitis pigmentosa. Biochem Med 30(1):49-52, 1983.
Van Tiggelen CJM. Nutritional aspects of senile dementia of the Alzheimer type (SDAT). J Orthomol Med 4(4):205-10, 1989.
Vessey DA. The biochemical basis for the conjugation of bile acids with either glycine or taurine. Biochem J 174:621-6, 1978.
Vodovokov AM, Glotova NM. Results of treating senile cataracts with taurine. Vestn Oftalmol 2:44-5, 1981.
Wang L Zhao N, Zhang F, et al. Effect of taurine on leucocyte function. Eu J Pharmacol. 2009. Epub ahead of print.
Wang WY, Liaw KY. Effect of a taurine-supplemented diet on conjugated bile acids in biliary surgical patients. JPEN J Parenter Enteral Nutr 15(3):294-7, 1991.
Watanabe A et al. Lowering of liver acetaldehyde but not ethanol concentrations by pretreatment with taurine in ethanol-loaded rats. Experientia 41(11):1421-2, 1985.
Yamada J et al. Effects of omega-aminosulfonic acids on lipid metabolism in dietary hyperlipidemic rats. J Pharmacobiodyn 6(6):373-80, 1983.
Yamanaka Y et al. Effect of dietary taurine on cholesterol gallstone formation and tissue cholesterol contents in mice. J Nutr Sci Vitaminol (Tokyo) 31(2):225-32, 1985.
Yamanaka Y et al. Stimulation of chenodeoxycholic acid excretion in hypercholesterolemic mice by dietary taurine. J Nutr Sci Vitaminol (Tokyo) 32(3):287-96, 1986.
Yamauchi-Takihara K et al. Taurine protection against experimental arterial calcinosis in mice. Biochem Biophys Res Commun 140(2):679-83, 1986.
Yamori Y et al. Cholesterol metabolism in arteriolipidosis-prone rats (ALA). Jpn Heart J 20 (Suppl):349-51, 1979.
Se også "Aminosyrer, kilder til" her
